Lianbo Li
Impact in
- Oncology top 10%
- Peptidase Inhibition and Analysis
- Cancer-related Molecular Pathways
- Molecular Biology top 10%
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Protein Kinase Regulation and GTPase Signaling
- Melanoma and MAPK Pathways
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 6
- Melanoma and MAPK Pathways 3
- Protein Tyrosine Phosphatases 3
- Ubiquitin and proteasome pathways 2
- Oncology 8
- Co-authors
- Kenneth D. Westover (16 shared papers)Nathanael S. Gray (7 shared papers)Sudershan Reddy Gondi (7 shared papers)David A. Scott (4 shared papers)Pasi A. Jänne (4 shared papers)Jarrod A. Marto (4 shared papers)Yuan Xiong (3 shared papers)Scott B. Ficarro (4 shared papers)
- Journals
- Cell chemical biology (4 papers)Pediatric Surgery International (2 papers)Medical Molecular Morphology (2 papers)Journal of Biological Chemistry (2 papers)Molecular Cancer (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Lianbo Li
45 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 102
- Oncology 284
- Molecular Biology 751
- Cancer Research 106
- Complementary and alternative medicine 56
- Hematology 53
Countries citing papers authored by Lianbo Li
This map shows the geographic impact of Lianbo Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianbo Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianbo Li more than expected).
Fields of papers citing papers by Lianbo Li
This network shows the impact of papers produced by Lianbo Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianbo Li. The network helps show where Lianbo Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Lianbo Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 215 | |
| 2 | 2017 | 126 | |
| 3 | 2019 | 121 | |
| 4 | 2017 | 107 | |
| 5 | 2016 | 74 | |
| 6 | 2016 | 53 | |
| 7 | 2021 | 47 | |
| 8 | 2010 | 43 | |
| 9 | 2020 | 33 | |
| 10 | 2017 | 28 | |
| 11 | 2016 | 26 | |
| 12 | 2015 | 25 | |
| 13 | 2013 | 24 | |
| 14 | 2017 | 21 | |
| 15 | 2022 | 20 | |
| 16 | 2020 | 15 | |
| 17 | 2021 | 13 | |
| 18 | 2016 | 13 | |
| 19 | 2019 | 13 | |
| 20 | 2020 | 11 |
About Lianbo Li
Lianbo Li is a scholar working on Molecular Biology, Oncology, Immunology, Atomic and Molecular Physics, and Optics and Ocean Engineering, having authored 46 papers that have together received 1.1k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (6 papers), Melanoma and MAPK Pathways (3 papers), Laser-Plasma Interactions and Diagnostics (3 papers), Protein Tyrosine Phosphatases (3 papers), Maritime Navigation and Safety (3 papers), Atomic and Molecular Physics (3 papers), Ubiquitin and proteasome pathways (2 papers) and Acupuncture Treatment Research Studies (2 papers). The work is most often cited by research in Oncology (284 citations), Molecular Biology (751 citations), Cancer Research (106 citations), Complementary and alternative medicine (56 citations) and Hematology (53 citations). Lianbo Li has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Kenneth D. Westover, Nathanael S. Gray, Sudershan Reddy Gondi, David A. Scott, Pasi A. Jänne, Jarrod A. Marto, Yuan Xiong, Scott B. Ficarro, Deepak Gurbani and Chunshan Quan. Their work appears in journals such as Cell chemical biology, Pediatric Surgery International, Medical Molecular Morphology, Journal of Biological Chemistry and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.